Report date: Apr 30, 2024
Conflict count: 350192
Publisher: Wiley (Blackwell Publishing)
Title count: 478
Conflict count: 16765


==========================================================

Created: 2021-04-07 07:48:30.0
ConfID: 6025704
CauseID: 1494967243
JT: CNS Neuroscience & Therapeutics
MD: null, 27 ,5,null,2021,Cover Image
DOI: 10.1111/cns.13410(Journal) (6025704-N )
DOI: 10.1111/cns.13644(Journal)
==========================================================

Created: 2022-01-07 05:23:08.0
ConfID: 6406732
CauseID: 1517258583
JT: CNS Neuroscience & Therapeutics
MD: null, 28 ,2,null,2022,Cover Image
DOI: 10.1111/cns.13667(Journal) (6406732-N )
DOI: 10.1111/cns.13665(Journal)
==========================================================

Created: 2022-07-05 02:51:24.0
ConfID: 6553997
CauseID: 1534571748
JT: CNS Neuroscience & Therapeutics
MD: null, 28 ,8,null,2022,Additional Cover
DOI: 10.1111/cns.13910(Journal) (6553997-N )
DOI: 10.1111/cns.13911(Journal)
==========================================================

Created: 2023-07-18 04:35:21.0
ConfID: 6903812
CauseID: 1581981879
JT: CNS Neuroscience & Therapeutics
MD: null, 29 ,8,null,2023,Front cover
DOI: 10.1111/cns.14374(Journal) (6903812-N )
DOI: 10.1111/cns.14375(Journal)
==========================================================

Created: 2023-10-10 01:49:03.0
ConfID: 6950656
CauseID: 1592422812
OtherID: 558918563
JT: CNS Neuroscience & Therapeutics
MD: Targum, 14 ,1,2,2008,Redefining Affective Disorders: Relevance for Drug Development
DOI: 10.1111/j.1527-3458.2008.00038.x(Journal) (6950656-N )
DOI: 10.1111/j.1755-5949.2008.00038.x(Journal)
==========================================================

Created: 2023-10-10 01:49:03.0
ConfID: 6950657
CauseID: 1592422812
OtherID: 558918563
JT: CNS Neuroscience & Therapeutics
MD: Weiser, 14 ,1,17,2008,Ambroxol: A CNS Drug?
DOI: 10.1111/j.1527-3458.2007.00032.x(Journal) (6950657-N )
DOI: 10.1111/j.1755-5949.2007.00032.x(Journal)
==========================================================

Created: 2023-10-10 01:49:03.0
ConfID: 6950658
CauseID: 1592422812
OtherID: 558918563
JT: CNS Neuroscience & Therapeutics
MD: Emond, 14 ,1,47,2008,PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter
DOI: 10.1111/j.1527-3458.2007.00033.x(Journal) (6950658-N )
DOI: 10.1111/j.1755-5949.2007.00033.x(Journal)